Two Sigma Advisers’s Neurotrope, Inc. Common NTRP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-57,700
Closed -$64K 2683
2020
Q3
$64K Buy
57,700
+8,800
+18% +$10.1K ﹤0.01% 2309
2020
Q2
$57K Buy
+48,900
New +$61.2K ﹤0.01% 2416

Other funds holding NTRP

Two Sigma Advisers's NTRP Position: Q4 2020 in Review

Two Sigma Advisers sold out of Neurotrope, Inc. Common (NTRP) in Q4 2020, closing a stake of 57,700 shares — an estimated $64K sold.

Two Sigma Advisers first reported a position in NTRP in Q2 2020 and held it in 2 quarters. The position peaked at $64K in Q3 2020. 1 fund tracked by Wall St. Rank holds NTRP as of Q4 2020.

  • Two Sigma Advisers reported no remaining Neurotrope, Inc. Common position as of Q4 2020 after selling out during the quarter.
  • Two Sigma Advisers sold 57,700 Neurotrope, Inc. Common shares in Q4 2020, an estimated $64K.
  • Two Sigma Advisers first reported a position in Neurotrope, Inc. Common in Q2 2020 and held it in 2 quarters.
  • Two Sigma Advisers's Neurotrope, Inc. Common position peaked at $64K in Q3 2020.
  • 1 fund tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q4 2020.

Based on Two Sigma Advisers's 13F filing for Q4 2020, filed 16 Feb 2021.